• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶 2 和 9 在不定型和心脏型恰加斯病患者中的表达存在差异。

Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas disease.

机构信息

Centro de Pesquisas René Rachou-FIOCRUZ, Belo Horizonte/MG, Brazil.

出版信息

Infect Immun. 2013 Oct;81(10):3600-8. doi: 10.1128/IAI.00153-13. Epub 2013 Jul 15.

DOI:10.1128/IAI.00153-13
PMID:23856618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3811750/
Abstract

Dilated chronic cardiomyopathy (DCC) from Chagas disease is associated with myocardial remodeling and interstitial fibrosis, resulting in extracellular matrix (ECM) changes. In this study, we characterized for the first time the serum matrix metalloproteinase 2 (MMP-2) and MMP-9 levels, as well as their main cell sources in peripheral blood mononuclear cells from patients presenting with the indeterminate (IND) or cardiac (CARD) clinical form of Chagas disease. Our results showed that serum levels of MMP-9 are associated with the severity of Chagas disease. The analysis of MMP production by T lymphocytes showed that CD8(+) T cells are the main mononuclear leukocyte source of both MMP-2 and MMP-9 molecules. Using a new 3-dimensional model of fibrosis, we observed that sera from patients with Chagas disease induced an increase in the extracellular matrix components in cardiac spheroids. Furthermore, MMP-2 and MMP-9 showed different correlations with matrix proteins and inflammatory cytokines in patients with Chagas disease. Our results suggest that MMP-2 and MMP-9 show distinct activities in Chagas disease pathogenesis. While MMP-9 seems to be involved in the inflammation and cardiac remodeling of Chagas disease, MMP-2 does not correlate with inflammatory molecules.

摘要

扩张型慢性克氏锥虫病(DCC)与心肌重构和间质纤维化有关,导致细胞外基质(ECM)变化。在这项研究中,我们首次描述了来自不定型(IND)或心脏型(CARD)克氏锥虫病患者外周血单个核细胞中血清基质金属蛋白酶 2(MMP-2)和 MMP-9 水平及其主要细胞来源。我们的结果表明 MMP-9 血清水平与克氏锥虫病的严重程度相关。对 T 淋巴细胞 MMP 产生的分析表明,CD8(+)T 细胞是 MMP-2 和 MMP-9 分子的主要单核白细胞来源。使用新的纤维化 3D 模型,我们观察到克氏锥虫病患者的血清诱导心脏球体中细胞外基质成分增加。此外,在克氏锥虫病患者中,MMP-2 和 MMP-9 与基质蛋白和炎症细胞因子显示出不同的相关性。我们的结果表明 MMP-2 和 MMP-9 在克氏锥虫病发病机制中表现出不同的活性。虽然 MMP-9 似乎参与了克氏锥虫病的炎症和心肌重构,但 MMP-2 与炎症分子不相关。

相似文献

1
Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas disease.基质金属蛋白酶 2 和 9 在不定型和心脏型恰加斯病患者中的表达存在差异。
Infect Immun. 2013 Oct;81(10):3600-8. doi: 10.1128/IAI.00153-13. Epub 2013 Jul 15.
2
Synergic and antagonistic relationship between MMP-2 and MMP-9 with fibrosis and inflammation in Chagas' cardiomyopathy.恰加斯心肌病中基质金属蛋白酶-2和基质金属蛋白酶-9与纤维化及炎症之间的协同和拮抗关系。
Parasite Immunol. 2017 Aug;39(8). doi: 10.1111/pim.12446. Epub 2017 Jun 16.
3
Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease.恰加斯病临床类型中中性粒细胞和单核细胞对基质金属蛋白酶2、9及细胞因子的差异表达
PLoS Negl Trop Dis. 2017 Jan 24;11(1):e0005284. doi: 10.1371/journal.pntd.0005284. eCollection 2017 Jan.
4
Matrix Metalloproteinase 2 and 9 Enzymatic Activities are Selectively Increased in the Myocardium of Chronic Chagas Disease Cardiomyopathy Patients: Role of TIMPs.基质金属蛋白酶 2 和 9 的酶活性在慢性恰加斯病心肌病患者的心肌中选择性增加:TIMP 的作用。
Front Cell Infect Microbiol. 2022 Mar 17;12:836242. doi: 10.3389/fcimb.2022.836242. eCollection 2022.
5
MMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas disease.MMP-2 和 MMP-9 血浆水平可能是慢性恰加斯病不确定和心脏临床形式进展的生物标志物。
Sci Rep. 2019 Oct 2;9(1):14170. doi: 10.1038/s41598-019-50791-z.
6
Evidence of Different IL-1β Activation Pathways in Innate Immune Cells From Indeterminate and Cardiac Patients With Chronic Chagas Disease.先天性免疫细胞中不确定和心脏慢性恰加斯病患者中不同的 IL-1β 激活途径的证据。
Front Immunol. 2019 Apr 18;10:800. doi: 10.3389/fimmu.2019.00800. eCollection 2019.
7
Galectin-3 (Gal-3) and the tissue inhibitor of matrix metalloproteinase (TIMP-2) as potential biomarkers for the clinical evolution of chronic Chagas cardiomyopathy.半乳糖凝集素-3(Gal-3)和基质金属蛋白酶组织抑制剂-2(TIMP-2)作为慢性恰加斯心肌病临床演变的潜在生物标志物。
Acta Trop. 2024 Apr;252:107153. doi: 10.1016/j.actatropica.2024.107153. Epub 2024 Feb 17.
8
Biomarkers and mortality in severe Chagas cardiomyopathy.严重查加斯心肌病中的生物标志物与死亡率
Glob Heart. 2015 Sep;10(3):173-80. doi: 10.1016/j.gheart.2015.07.003.
9
Endogenous osteopontin induces myocardial CCL5 and MMP-2 activation that contributes to inflammation and cardiac remodeling in a mouse model of chronic Chagas heart disease.内源性骨桥蛋白诱导心肌 CCL5 和 MMP-2 的激活,导致慢性恰加斯心脏病小鼠模型中的炎症和心脏重构。
Biochim Biophys Acta Mol Basis Dis. 2018 Jan;1864(1):11-23. doi: 10.1016/j.bbadis.2017.10.006. Epub 2017 Oct 4.
10
Matrix metalloproteinases 2 and 9 as diagnostic markers in the progression to Chagas cardiomyopathy.基质金属蛋白酶 2 和 9 作为进展为恰加斯心肌病的诊断标志物。
Am Heart J. 2013 Apr;165(4):558-66. doi: 10.1016/j.ahj.2013.01.001. Epub 2013 Feb 15.

引用本文的文献

1
Exploring the Dimensions of Pre-Clinical Research: 3D Cultures as an Investigative Model of Cardiac Fibrosis in Chagas Disease.探索临床前研究的维度:3D培养作为恰加斯病心脏纤维化的研究模型
Biomedicines. 2024 Jun 25;12(7):1410. doi: 10.3390/biomedicines12071410.
2
Biomarkers and Echocardiographic Predictors of Cardiovascular Outcome in Patients With Chronic Chagas Disease.慢性恰加斯病患者心血管结局的生物标志物和超声心动图预测指标。
J Am Heart Assoc. 2023 Jun 20;12(12):e028810. doi: 10.1161/JAHA.122.028810. Epub 2023 Jun 14.
3
Plasma Levels of Matrix Metalloproteinases 2 and 9 in Patients with Chronic Chagas Heart Disease and Systemic Arterial Hypertension: Correlation with TGF-Beta Plasma Levels.慢性恰加斯心脏病和系统性动脉高血压患者血浆中基质金属蛋白酶2和9的水平:与转化生长因子-β血浆水平的相关性
Cardiol Res Pract. 2023 Apr 19;2023:8484697. doi: 10.1155/2023/8484697. eCollection 2023.
4
Risk Factors for Progression to Chronic Chagas Cardiomyopathy: A Systematic Review and Meta-Analysis.进展为慢性克氏锥虫心肌病的危险因素:系统评价和荟萃分析。
Am J Trop Med Hyg. 2023 Feb 27;108(4):791-800. doi: 10.4269/ajtmh.22-0630. Print 2023 Apr 5.
5
Call for Consensus in the Evaluation of Circulating Matrix Metalloproteinases in Chagas Disease.关于恰加斯病循环基质金属蛋白酶评估的共识呼吁。
Am J Trop Med Hyg. 2022 Jul 5;107(3):495-9. doi: 10.4269/ajtmh.21-0860.
6
Diffuse Myocardial Fibrosis and Cardiomyocyte Diameter Are Associated With Heart Failure Symptoms in Chagas Cardiomyopathy.弥漫性心肌纤维化和心肌细胞直径与恰加斯心肌病的心力衰竭症状相关。
Front Cardiovasc Med. 2022 Jun 17;9:880151. doi: 10.3389/fcvm.2022.880151. eCollection 2022.
7
Matrix Metalloproteinase 2 and 9 Enzymatic Activities are Selectively Increased in the Myocardium of Chronic Chagas Disease Cardiomyopathy Patients: Role of TIMPs.基质金属蛋白酶 2 和 9 的酶活性在慢性恰加斯病心肌病患者的心肌中选择性增加:TIMP 的作用。
Front Cell Infect Microbiol. 2022 Mar 17;12:836242. doi: 10.3389/fcimb.2022.836242. eCollection 2022.
8
Selenium, TGF-Beta and Infectious Endemic Cardiopathy: Lessons from Benchwork to Clinical Application in Chagas Disease.硒、TGF-β与感染性地方性心脏病:恰加斯病从实验室到临床应用的经验教训。
Biomolecules. 2022 Feb 23;12(3):349. doi: 10.3390/biom12030349.
9
Cardiac Fibrosis and Changes in Left Ventricle Function in Patients with Chronic Chagas Heart Disease.慢性恰加斯心脏病患者的心肌纤维化和左心室功能变化。
Arq Bras Cardiol. 2021 Dec;117(6):1081-1090. doi: 10.36660/abc.20200597.
10
Effect of N‑terminal region of human parvovirus B19‑VP1 unique region on cardiac injury in naïve mice.人细小病毒 B19VP1 独特区 N 端区域对新生小鼠心脏损伤的影响。
Mol Med Rep. 2021 Nov;24(5). doi: 10.3892/mmr.2021.12399. Epub 2021 Sep 3.

本文引用的文献

1
Zymography methods for visualizing hydrolytic enzymes.酶谱法用于可视化水解酶。
Nat Methods. 2013 Mar;10(3):211-20. doi: 10.1038/nmeth.2371.
2
Membrane-associated matrix proteolysis and heart failure.膜相关基质蛋白水解与心力衰竭。
Circ Res. 2013 Jan 4;112(1):195-208. doi: 10.1161/CIRCRESAHA.112.266882.
3
Oral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas disease.口服转化生长因子-β信号抑制剂 GW788388 可预防恰加斯病性心脏病纤维化。
PLoS Negl Trop Dis. 2012;6(6):e1696. doi: 10.1371/journal.pntd.0001696. Epub 2012 Jun 12.
4
Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity.来自恰加斯病不确定期患者的 Foxp3+CD25(high) CD4+ 调节性 T 细胞可以抑制效应细胞和细胞因子,并显示与疾病严重程度改变的相关性。
Immunobiology. 2012 Aug;217(8):768-77. doi: 10.1016/j.imbio.2012.04.008. Epub 2012 May 9.
5
Characterization of CD4⁺ cytotoxic lymphocytes and apoptosis markers induced by Trypanossoma cruzi infection.鉴定克氏锥虫感染诱导的 CD4+细胞毒性淋巴细胞和凋亡标志物。
Scand J Immunol. 2012 Sep;76(3):311-9. doi: 10.1111/j.1365-3083.2012.02730.x.
6
Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease.不定型 Chagas 病患者中性粒细胞和单核细胞吞噬能力受损,主要吞噬相关细胞表面分子下调,导致整体调节细胞因子谱发生变化。
Immunobiology. 2012 Oct;217(10):1005-16. doi: 10.1016/j.imbio.2012.01.014. Epub 2012 Jan 20.
7
Different prognostic impact of the tissue Doppler-derived E/e' ratio on mortality in Chagas cardiomyopathy patients with heart failure.组织多普勒衍生的 E/e' 比值对心力衰竭的恰加斯心肌病患者死亡率的不同预后影响。
J Heart Lung Transplant. 2012 Jun;31(6):634-41. doi: 10.1016/j.healun.2012.01.865. Epub 2012 Feb 1.
8
Clinical aspects of Chagas disease and implications for novel therapies.恰加斯病的临床方面及其对新型疗法的意义。
Drug Dev Res. 2011 Sep;72(6):471-479. doi: 10.1002/ddr.20454.
9
Circulating matrix metalloproteinases and their inhibitors in hypertension.高血压患者血液中的基质金属蛋白酶及其抑制剂
Clin Chim Acta. 2012 Apr 11;413(7-8):656-62. doi: 10.1016/j.cca.2011.12.021. Epub 2012 Jan 8.
10
Nuclear localization of matrix metalloproteinases.基质金属蛋白酶的核定位
Prog Histochem Cytochem. 2012 Mar;47(1):27-58. doi: 10.1016/j.proghi.2011.12.002. Epub 2012 Jan 5.